Echo Therapeutics (ECTE) Reports Q1 Loss of $0.23/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.23), versus ($0.72) reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
- Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
